US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 2.130
  • +0.330+18.33%
Close Apr 18 16:00 ET
  • 2.170
  • +0.040+1.88%
Post 19:18 ET
33.56MMarket Cap-1852P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
20.55%14.58M
56.86%5.11M
-12.05%3.11M
31.47%3.45M
8.72%2.9M
-5.63%12.09M
24.11%3.26M
-23.71%3.54M
-35.62%2.62M
81.11%2.67M
Selling and administrative expenses
16.29%8.53M
73.53%3.17M
-9.46%1.77M
0.00%1.71M
1.95%1.89M
-31.95%7.34M
-4.34%1.83M
-44.51%1.95M
-57.02%1.71M
33.91%1.85M
-General and administrative expense
16.29%8.53M
73.53%3.17M
-9.46%1.77M
0.00%1.71M
1.95%1.89M
-31.95%7.34M
-4.34%1.83M
-44.51%1.95M
-57.02%1.71M
33.91%1.85M
Research and development costs
27.12%6.04M
35.60%1.94M
-15.21%1.35M
90.46%1.74M
24.02%1.02M
134.18%4.75M
100.03%1.43M
41.18%1.59M
858.93%911.69K
790.99%818.89K
Operating profit
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.63%-12.09M
-24.11%-3.26M
23.71%-3.54M
35.62%-2.62M
-81.11%-2.67M
Net non-operating interest income expense
Other net income (expense)
Income before tax
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Income tax
Net income
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Net income continuous Operations
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Minority interest income
Net income attributable to the parent company
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
Basic earnings per share
-2.68%-1.15
-35.71%-0.38
25.00%-0.24
-7.69%-0.28
3.85%-0.25
24.83%-1.12
-27.27%-0.28
30.43%-0.32
54.39%-0.26
-68.26%-0.26
Diluted earnings per share
-2.68%-1.15
-35.71%-0.38
25.00%-0.24
-7.69%-0.28
3.85%-0.25
24.83%-1.12
-27.27%-0.28
30.43%-0.32
54.39%-0.26
-68.26%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 20.55%14.58M56.86%5.11M-12.05%3.11M31.47%3.45M8.72%2.9M-5.63%12.09M24.11%3.26M-23.71%3.54M-35.62%2.62M81.11%2.67M
Selling and administrative expenses 16.29%8.53M73.53%3.17M-9.46%1.77M0.00%1.71M1.95%1.89M-31.95%7.34M-4.34%1.83M-44.51%1.95M-57.02%1.71M33.91%1.85M
-General and administrative expense 16.29%8.53M73.53%3.17M-9.46%1.77M0.00%1.71M1.95%1.89M-31.95%7.34M-4.34%1.83M-44.51%1.95M-57.02%1.71M33.91%1.85M
Research and development costs 27.12%6.04M35.60%1.94M-15.21%1.35M90.46%1.74M24.02%1.02M134.18%4.75M100.03%1.43M41.18%1.59M858.93%911.69K790.99%818.89K
Operating profit -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.63%-12.09M-24.11%-3.26M23.71%-3.54M35.62%-2.62M-81.11%-2.67M
Net non-operating interest income expense
Other net income (expense)
Income before tax -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Income tax
Net income -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Net income continuous Operations -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Minority interest income
Net income attributable to the parent company -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M23.71%-3.54M34.55%-2.62M-81.11%-2.67M
Basic earnings per share -2.68%-1.15-35.71%-0.3825.00%-0.24-7.69%-0.283.85%-0.2524.83%-1.12-27.27%-0.2830.43%-0.3254.39%-0.26-68.26%-0.26
Diluted earnings per share -2.68%-1.15-35.71%-0.3825.00%-0.24-7.69%-0.283.85%-0.2524.83%-1.12-27.27%-0.2830.43%-0.3254.39%-0.26-68.26%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg